Recent studies on genetic and epigenetic modifiers of NAFLD progression suggest that the I148M PNPLA3 variant is the major common genetic determinant of NAFLD [12]. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.